LIORESAL
What it isGABA-B receptor agonist; spasticity of spinal origin.
Why this oneIntrathecal delivery makes it uniquely useful for severe spinal spasticity when oral sedation prevents adequate treatment.
What limits itRenal accumulation can cause encephalopathy; abrupt withdrawal can cause rebound spasticity, delirium or seizures — especially from a pump.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Spasticity (e.g., multiple sclerosis, spinal cord conditions) | Adult | 5 mg TID | 40-80 mg/day divided (titrate) | 80 mg/day (20 mg QID) |
Titration Increase dose every 3 days per titration schedule
Renal Undefined
Hepatic Undefined
Pregnancy Undefined
Lactation Undefined
NO BOXED WARNINGS
Principal riskAbrupt withdrawal can cause seizures and rebound spasticity
Cost, est. cash$4–$80/month
Generic entry1988
Legacy pregnancy categoryUnknown / historical label unavailable
Defining liabilityGenerally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.

Open Baclofen in the interactive console ↗

